TY - JOUR
T1 - Investigating gut permeability in animal models of disease
AU - González-González, Marianela
AU - Díaz-Zepeda, Camilo
AU - Eyzaguirre-Velásquez, Johana
AU - González-Arancibia, Camila
AU - Bravo, Javier A.
AU - Julio-Pieper, Marcela
N1 - Publisher Copyright:
© 2019 Frontiers Media S.A. All Rights Reserved.
PY - 2019
Y1 - 2019
N2 - A growing number of investigations report the association between gut permeability and intestinal or extra-intestinal disorders under the basis that translocation of gut luminal contents could affect tissue function, either directly or indirectly. Still, in many cases it is unknown whether disruption of the gut barrier is a causative agent or a consequence of these conditions. Adequate experimental models are therefore required to further understand the pathophysiology of health disorders associated to gut barrier disruption and to develop and test pharmacological treatments. Here, we review the current animal models that display enhanced intestinal permeability, and discuss (1) their suitability to address mechanistic questions, such as the association between gut barrier alterations and disease and (2) their validity to test potential treatments for pathologies that are characterized by enhanced intestinal permeability.
AB - A growing number of investigations report the association between gut permeability and intestinal or extra-intestinal disorders under the basis that translocation of gut luminal contents could affect tissue function, either directly or indirectly. Still, in many cases it is unknown whether disruption of the gut barrier is a causative agent or a consequence of these conditions. Adequate experimental models are therefore required to further understand the pathophysiology of health disorders associated to gut barrier disruption and to develop and test pharmacological treatments. Here, we review the current animal models that display enhanced intestinal permeability, and discuss (1) their suitability to address mechanistic questions, such as the association between gut barrier alterations and disease and (2) their validity to test potential treatments for pathologies that are characterized by enhanced intestinal permeability.
KW - Barrier
KW - Epithelium
KW - Gastrointestinal disorders
KW - Gut
KW - Permeability
UR - http://www.scopus.com/inward/record.url?scp=85065552585&partnerID=8YFLogxK
U2 - 10.3389/fphys.2018.01962
DO - 10.3389/fphys.2018.01962
M3 - Review article
AN - SCOPUS:85065552585
SN - 1664-042X
VL - 10
JO - Frontiers in Physiology
JF - Frontiers in Physiology
IS - JAN
M1 - 1962
ER -